Serum S-100beta protein release in coronary artery bypass grafting: laminar versus pulsatile flow

B Kusch1, S Vogt, A S Sirat

  • 1Clinic for Cardiac Surgery, Philipps University Hospital, Marburg, Germany.

Insights

Pulsatile cardiopulmonary bypass (CPB) may offer better neuroprotection than laminar flow during coronary artery bypass grafting (CABG). Lower S-100beta serum marker levels suggest reduced cerebral injury with pulsatile flow.

Area of Science:

  • Cardiovascular Surgery
  • Neuroprotection
  • Biomarkers

Background:

  • Cerebral injury is a significant complication following cardiopulmonary bypass (CPB).
  • The S-100beta serum marker is a potential indicator of cerebral injury during and after CPB.
  • Limited research directly compares laminar versus pulsatile pump flow effects on S-100beta levels and neuroprotection in CABG.

Purpose of the Study:

  • To compare S-100beta serum levels in patients undergoing CABG with laminar versus pulsatile pump flow.
  • To investigate the potential neuroprotective effects of pulsatile pump flow during CPB.

Main Methods:

  • A study involving 21 first-time CABG patients without prior cerebral disease.
  • Patients were divided into two groups: laminar flow (n=10) and pulsatile flow (n=11) using a Stöckert roller pump.
  • Serum S-100beta levels were measured using a monoclonal immunoradiometric assay at five time points, from pre-intubation to 36 hours post-surgery.

Main Results:

  • Peak S-100beta levels were observed at skin closure.
  • Median S-100beta levels were lower in the pulsatile flow group compared to the laminar flow group.
  • The study's small sample size and wide data range resulted in non-significant findings.

Conclusions:

  • Pulsatile pump flow during CPB may offer a more neuroprotective effect than laminar flow.
  • Lower S-100beta values in the pulsatile group suggest a potential benefit in reducing cerebral injury.
Abstract